Mathematical Analysis of Repeated BCG Administration in Type 1 Diabetes: Improved Macrophage Response and Prolonged β-Cell Viability

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

This study develops an extended mathematical model to investigate innate immune dynamics in Type 1 Diabetes (T1D), focusing on the interplay between pro-inflammatory M1 macrophages, anti-inflammatory M2 macrophages, and pancreatic β-cells, which was shown in H.Hamam (2023). This model incorporates the immunomodulatory effect of Bacillus Calmette-Guérin (BCG) vaccination by representing each dose as a pulse-like input, implemented through a finite-duration Heaviside function, together with first-order elimination to describe the decay of the vaccine within the system. Simulation results after a single BCG pulse show a temporary decrease in M2 levels, followed by an increase in M2 macrophages, leading to a transient rise in β-cell levels. However, a key mechanism of this study is that repeated BCG doses generate a much clearer and more sustained improvement in β-cell levels compared to a single dose. Multiple-dose protocols produce more sustained reductions in inflammatory pressure, resulting in extended periods of β-cell preservation. Given uncertainties in several parameter values, a local sensitivity analysis was performed. The results show that parameters governing M2-mediated activation of β-cells

Article activity feed